| Characteristics |
Hippocampal-sparing AD
(n = 79, 8.2%) |
Limbic-predom. AD (n = 85, 8.9%) |
Typical AD (n = 769, 82.5%) |
P value |
| Women |
59.5% |
64.7%* |
67.5%* |
* versus HS P < 0.01 |
| Age at death |
76.3 ± 8.6 |
84.9 ± 3.8* |
81.3 ± 9.2* |
* versus HS P < 0.01 |
| Age at onset |
68.0 ± 10.0 |
73.8 ± 6.4* |
79.7 ± 3.8* |
P < 0.01; * versus HS <0.001 |
| Disease duration |
7.4 ± 3.6** |
4.8 ± 2.6*** |
9.1 ± 4.3* |
***P < 0.001; ** versus HS P < 0.001 |
| MMSE final (mean) |
10 (n = 20) |
11.5 (n = 16) |
4.6 (n = 78)* |
* versus other forms P < 0.01 |
| Braak NFT stage (mean) |
4.5 (2–5) |
4.5 (3–5) |
5.6 (5–6) |
|
| Cerebrovascular pathology |
34.2% * |
41.1% |
36.4% * |
* versus. LP P < 0.01 |
| Lewy body pathology |
24.9% * |
3.5% |
8.2% |
* versus. other forms P < 0.001 |
